Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Clinical trial NCT03392909 · UNKNOWN
Trial details
- NCT number
- NCT03392909
- Sponsor
- University of Southern California
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-05
- Primary completion
- 2023-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.